SB-773812 Administered In Adults With Schizophrenia
NCT00259870
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
338
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
SB-773812
DRUG:
Olanzapine
Sponsor
GlaxoSmithKline